Novartis, Johnson & Johnson and Consort Medical all returned to invest in the company's series C round as it looks to commercialise its diagnostic testing system.

The Kraft-backed biotechnology company, which is developing treatments for neuromuscular disorders, has gone public just five months after a $40m series A round.

Cerner Corporation and NextCode Health have backed a series B round that will fund the launch of Claritas' new sequencing test for paediatric disorders.

Brandon Point Industries has backed a $25m round for Xenex, which manufactures robotic disinfection systems for healthcare facilities.

Microneedle patch developer Zosano secured the cash from strategic partner Eli Lilly concurrently to a $47.5m initial public offering.

Iora Health has raised a $28m round from backers including Rice University, increasing its funding total to $48.5m.

Crossover Health, which provides on-site healthcare for big companies, has received $15m from Wells Fargo-backed Norwest.

Iora Health has raised a $28m round from backers including General Electric, increasing its funding total to $48.5m.

Colorado University licenses out cataract surgery device to Mile High Ophthalmics.